Havrix suspension 720IU, 1 dose 0.5ml syringes 1pc

Composition

1 dose of suspension for injection for children contains:

Active ingredient:

hepatitis A virus antigen 720 UNITS (ELISA)

Pharmacological action

Havrix provides active immunity against hepatitis A virus lasting at least 15-20 years (when using a two-dose vaccination scheme).

In clinical studies, it was found that antibodies to the hepatitis A antigen on the 15th day after vaccination in persons aged 18-50 years are formed in 88% of cases,1-18 years-in 93%; one month after vaccination-in 99% of cases in both age groups. The use of the vaccine is effective in the early incubation period of the disease.

The effectiveness of the vaccine does not decrease in the presence of maternal antibodies to the hepatitis A virus or antibodies to the hepatitis A virus passively administered in the blood of the vaccinated person.

Indications

Active immunoprophylaxis of hepatitis A.

Use during pregnancy and lactation

Only if absolutely necessary.

Contraindications

Hypersensitivity to any of the components of the vaccine.

Acute and chronic inflammatory diseases accompanied by fever (vaccination is postponed until the body temperature returns to normal).

Side effects

Local users: ~ in 4% of cases — swelling, redness at the injection site;

Systemic: 0.8-12.8% of cases — headache, malaise, nausea, vomiting, loss of appetite (do not require treatment, the duration does not exceed 24 hours).

Interaction

It is not allowed to mix in the same syringe with other vaccines.

It is combined with all vaccinations of the national calendar and all vaccines for travelers.

How to take, course of use and dosage

of Havrix is administered intramuscularly.

Children from 1 year of age and adolescents up to 18 years of age inclusive: 720 units (0.5 ml) in the anterolateral area of the femoral or deltoid muscle.

6-12 months after the first vaccination, it is recommended to repeat it.

Patients with thrombocytopenia or blood clotting disorders are administered subcutaneously.

Special instructions

If Havrix is administered simultaneously with other vaccines, injections should be given at different locations.

In patients undergoing programmed hemodialysis and those with severe immunodeficiency, the formation of antibodies to the hepatitis A antigen after use of a single dose of the vaccine may be insufficient, so additional doses are recommended for such patients.

Form of production

Suspension for injection for children

Storage conditions

At a temperature of 2-8 °C (do not freeze)

Shelf life

3 years

Active ingredient

Vaccine for the prevention of viral hepatitis A

Conditions of release from pharmacies

By prescription

Dosage form

suspension for injection